Pulmonary hypertension primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Genetic and environmental factors are involved in pulmonary hypertension (PH); therefore, not all cases of PH are preventable. | Genetic and environmental factors are involved in pulmonary hypertension (PH); therefore, not all cases of PH are preventable. PH that is secondary to other diseases such as [[left heart failure]], chronic [[lung]] disease, chronic [[liver]] disease, and [[collagen vascular disease]]s among others can be prevented by the early and optimal treatment of these medical conditions. Patients who are at an elevated risk for developing pulmonary arterial hypertension (PAH) must be monitored for the occurrence of symptoms of PAH. Patients at risk for PAH include subjects with [[systemic sclerosis]] or with genetic predisposition. | ||
==Primary Prevention== | ==Primary Prevention== | ||
*The primary prevention of the pulmonary hypertension is as | *The primary prevention of the pulmonary hypertension is as follows:<ref name="pmid24937180">{{cite journal| author=Taichman DB, Ornelas J, Chung L, Klinger J, Lewis S, Mandel J et al.| title=Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline. | journal=Chest | year= 2014 | volume= | issue= | pages= | pmid=24937180 | doi=10.1378/chest.14-0793 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24937180 }} </ref> | ||
*Genetic and environmental factors are involved in pulmonary hypertension (PH); therefore, not all cases of PH are preventable. | **[[Genetic]] and [[Environmental factor|environmental factors]] are involved in pulmonary hypertension (PH); therefore, not all cases of PH are preventable. | ||
*PH that is secondary to other diseases such as [[left heart failure]], chronic [[lung]] disease, chronic [[liver]] disease, and [[collagen vascular disease]]s among others can be prevented by the early and optimal treatment of these medical conditions. | **PH that is secondary to other diseases such as [[left heart failure]], chronic [[lung]] disease, chronic [[liver]] disease, and [[collagen vascular disease]]s among others can be prevented by the early and optimal treatment of these medical conditions. | ||
*Patients who are at elevated risk for developing pulmonary arterial hypertension (PAH) must be monitored for the occurrence of symptoms of PAH. | **Patients who are at an elevated risk for developing pulmonary arterial hypertension (PAH) must be monitored for the occurrence of symptoms of PAH. Patients at risk for PAH include subjects with [[systemic sclerosis]] or with a genetic predisposition. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category: | {{WH}} | ||
{{WS}} | |||
[[Category:Medicine]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category: | [[Category:Emergency medicine]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
Latest revision as of 17:11, 9 June 2021
|
Pulmonary Hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pulmonary hypertension primary prevention On the Web |
|
American Roentgen Ray Society Images of Pulmonary hypertension primary prevention |
|
Risk calculators and risk factors for Pulmonary hypertension primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Genetic and environmental factors are involved in pulmonary hypertension (PH); therefore, not all cases of PH are preventable. PH that is secondary to other diseases such as left heart failure, chronic lung disease, chronic liver disease, and collagen vascular diseases among others can be prevented by the early and optimal treatment of these medical conditions. Patients who are at an elevated risk for developing pulmonary arterial hypertension (PAH) must be monitored for the occurrence of symptoms of PAH. Patients at risk for PAH include subjects with systemic sclerosis or with genetic predisposition.
Primary Prevention
- The primary prevention of the pulmonary hypertension is as follows:[1]
- Genetic and environmental factors are involved in pulmonary hypertension (PH); therefore, not all cases of PH are preventable.
- PH that is secondary to other diseases such as left heart failure, chronic lung disease, chronic liver disease, and collagen vascular diseases among others can be prevented by the early and optimal treatment of these medical conditions.
- Patients who are at an elevated risk for developing pulmonary arterial hypertension (PAH) must be monitored for the occurrence of symptoms of PAH. Patients at risk for PAH include subjects with systemic sclerosis or with a genetic predisposition.
References
- ↑ Taichman DB, Ornelas J, Chung L, Klinger J, Lewis S, Mandel J; et al. (2014). "Pharmacological Therapy for Pulmonary Arterial Hypertension in Adults: CHEST Guideline". Chest. doi:10.1378/chest.14-0793. PMID 24937180.